The growing interest of pharmaceutical and agri-business companies in genes from natural products is generating a complex set of conflicts with Third World nations, where most of the world's genetic diversity is to be found.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Harnessing biodiversity: the Malagasy Institute of Applied Research (IMRA)
BMC International Health and Human Rights Open Access 13 December 2010
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Macilwain, C. When rhetoric hits reality in debate on bioprospecting. Nature 392, 535–536 (1998). https://doi.org/10.1038/33237
Issue Date:
DOI: https://doi.org/10.1038/33237
This article is cited by
-
Locating Responsible Research and Innovation Within Access and Benefit Sharing Spaces of the Convention on Biological Diversity: the Challenge of Emerging Technologies
NanoEthics (2016)
-
Exploitation of Microbial Diversity for Novel Products
Proceedings of the National Academy of Sciences, India Section B: Biological Sciences (2012)
-
Harnessing biodiversity: the Malagasy Institute of Applied Research (IMRA)
BMC International Health and Human Rights (2010)
-
David Pearce and the economic valuation of biodiversity
Environmental and Resource Economics (2007)
-
Land-use system modeling and analysis of shaded cacao production in Belize
Agroforestry Systems (2005)
